Hypertrophic cardiomyopathy (HCM) is associated with poor prognosis. It has been reported that there is no difference in in‐hospital mortality after acute myocardial infarction (AMI) between patients with and without… Click to show full abstract
Hypertrophic cardiomyopathy (HCM) is associated with poor prognosis. It has been reported that there is no difference in in‐hospital mortality after acute myocardial infarction (AMI) between patients with and without HCM. However, whether there is a difference in long‐term survival after AMI between patients with and without HCM remains unclear.
               
Click one of the above tabs to view related content.